a lot of people in my family die of cancer, and I am always interested in the
latest cancer breakthroughs. What are some of the breakthroughs that I may have
missed? This is more of a hobby for me than anything else, but it’s always nice
to see where the health industry is at in terms of a cure or potential relief
A lot of
“breakthroughs,” seem to come out every month, but you need to really see what
these “breakthroughs” actually entail.
advancements have found that cancer acts differently depending on which person
has the disease. The finding is a lot more important than it sounds when you
read it. What the finding indicates is that the mutations that occur in the genes
and on the cellular level are different for every person and every tumor.
This is a
clear sign that a personalized treatment approach is needed and may be able to
impact survival rates.
seeing major changes in chemotherapy protection in the works. Researchers have
Sodium (GM1) pig brain with great results. The substance is
known as a neuroprotector and has been shown to prevent neurotoxicity in advanced
Previous studies have shown that pig brain can
help reduce oxaliplatin-induced neurotoxicity.
This is very important because neurotoxicity is
the main reason that a lot of people stop chemotherapy. Heavily acute
neurotoxicity is the main adverse side effect of chemo. When injected, GM1 can
help alleviate these side effects allowing a patient to continue with their
chemotherapy for longer with a great rate of success.
But there have also been a lot advancement of
rare cancer treatments and options, too.
I recommend reading the report by ASCO to view them all. A lot of the
- Targeted therapies for a rare form of
thyroid cancer have been able to produce positive responses in 66% of
- Desmoid tumors are starting to react to
Sorafenib for the first time ever to provide an improvement in progression-free
- Luteium Lu 177 dotatate has been
promising in delivering targeted radiation to tumor cells, reducing the risk of
progression and death by as much as 79% for patients that have been diagnosed
with advanced midgut neuroendocrine tumors.
- A rare cancer of the joints has also
found its first promising treatment in colony-stimulating factor-1 inhibitor pexidartinib with a
39.3% response rate.
also been landmark advancements in molecular diagnosis, immunotherapy
advancements and new success with targeted therapy options. Researchers are
trying to target strategies that can be employed to help the response rate to
support really matters, and cancer death rates are on the decline since 1991
when they reached peak levels. Death rates are down 27% with 130+ new cancer
drugs approved since 2006. Survival rates are increasing with congress
approving increasing budgets in funding over the last four years. The additional
funding and promising studies are a positive for cancer sufferers.
is far from being eliminated, science is making strides to increase survival
rates and stop the advancement of many cancers.